{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:16:02Z","timestamp":1791389762846,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07323"],"award-info":[{"award-number":["JP23K07323"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08248"],"award-info":[{"award-number":["JP20K08248"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K08313"],"award-info":[{"award-number":["JP19K08313"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K07882"],"award-info":[{"award-number":["JP22K07882"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07240"],"award-info":[{"award-number":["JP23K07240"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ymgme.2024.108497","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T15:44:43Z","timestamp":1715787883000},"page":"108497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Promyelinating drugs ameliorate oligodendrocyte pathologies in a mouse model of Krabbe disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Naoko","family":"Inamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineyoshi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Enokido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108497_bb0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Suzuki Y globoid cell leukodystrophy (Krabbe\u2019s disease): deficiency of galactocerebroside \u03b2-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2024.108497_bb0010","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Krabbe disease (globoid cell leukodystrophy)","author":"Wenger","year":"2019"},{"key":"10.1016\/j.ymgme.2024.108497_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/brain\/39.1-2.74","article-title":"A new familial, infantile form of brain sclerosis","volume":"39","author":"Krabbe","year":"1916","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2024.108497_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0028-1091865","article-title":"Infantile globoid cell leucodystrophy (Krabbe's disease). A clinical and genetic study of 32 Swedish cases 1953\u20131967","volume":"1","author":"Hagberg","year":"1969","journal-title":"Neurop\u00e4diatrie"},{"key":"10.1016\/j.ymgme.2024.108497_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2014.09.046","article-title":"History, genetic, and recent advances on Krabbe disease","volume":"555","author":"Graziano","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2024.108497_bb0030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0006-291X(72)90381-6","article-title":"Globoid cell leukodystropy: additional deficiency of psychosine galactosidase","volume":"48","author":"Miyatake","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2024.108497_bb0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.6719111","article-title":"Progressive accumulation of toxic metabolite in a genetic leukodystrophy","volume":"224","author":"Igisu","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2024.108497_bb0040","first-page":"1","article-title":"Clemastine, in: XPharm: the comprehensive pharmacology reference","author":"Minigh","year":"2008","journal-title":"Elsevier"},{"key":"10.1016\/j.ymgme.2024.108497_bb0045","doi-asserted-by":"crossref","unstructured":"F. Mei, S.P.J. Fancy, Y-A.A. Shen, J. Niu, C. Zhao, B. Presley, E. Miao, S. Lee, S.R. Mayoral, S.A. Redmond, Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis, Nat. Med. 20 (2014) 954\u2013960.","DOI":"10.1038\/nm.3618"},{"key":"10.1016\/j.ymgme.2024.108497_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/brain\/awx312","article-title":"Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury","volume":"141","author":"Cree","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2024.108497_bb0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12264-015-1555-3","article-title":"Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ymgme.2024.108497_bb0060","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41593-019-0380-9","article-title":"Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug","volume":"22","author":"Barak","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymgme.2024.108497_bb0065","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.neuron.2021.05.012","article-title":"Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer\u2019s disease","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.ymgme.2024.108497_bb0070","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1093\/brain\/awad057","article-title":"Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt-Hopkins syndrome","volume":"146","author":"Bohlen","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2024.108497_bb0075","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2024.108497_bb0080","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1016\/j.bmc.2016.09.038","article-title":"Sobetirome prodrug esters with enhanced blood-brain barrier permeability","volume":"24","author":"Placzek","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymgme.2024.108497_bb0085","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.bmc.2017.03.047","article-title":"Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration","volume":"25","author":"Ferrara","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymgme.2024.108497_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126329","article-title":"Myelin repair stimulated by CNS-selective thyroid hormone action","volume":"4","author":"Hartley","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2024.108497_bb0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.chembiol.2020.02.008","article-title":"Pharmacological complementation remedies an inborn error of lipid metabolism","volume":"27","author":"Hartley","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ymgme.2024.108497_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2018.08.023","article-title":"Developmental defects and aberrant accumulation of endogenous psychosine in oligodendrocytes in a murine model of Krabbe disease","volume":"120","author":"Inamura","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2024.108497_bb0105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.21927","article-title":"Dicer ablation in oligodendrocytes provokes neuronal impairment in mice","volume":"66","author":"Shin","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2024.108497_bb0110","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","article-title":"Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination","volume":"65","author":"Dugas","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ymgme.2024.108497_bb0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuron.2010.02.018","article-title":"MicroRNA-mediated control of oligodendrocyte differentiation","volume":"65","author":"Zhao","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ymgme.2024.108497_bb0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.devcel.2017.03.001","article-title":"miR-219 cooperates with miR-338 in myelination and promotes myelin repair in the CNS","volume":"40","author":"Wang","year":"2017","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymgme.2024.108497_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12951","article-title":"Reduction in miR-219 expression underlies cellular pathogenesis of oligodendrocytes in a mouse model of Krabbe disease","volume":"31","author":"Inamura","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymgme.2024.108497_bb0130","doi-asserted-by":"crossref","first-page":"20097","DOI":"10.1073\/pnas.1912108116","article-title":"Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2024.108497_bb0135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jnc.15876","article-title":"Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination","volume":"166","author":"Watanabe","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2024.108497_bb0140","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1471-4159.1996.66031118.x","article-title":"Molecular cloning and expression of cDNA for murine galactocerebrosidase and mutation analysis of the twitcher mouse, a model of Krabbe's disease","volume":"66","author":"Sakai","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2024.108497_bb0145","first-page":"854","article-title":"Purification of oligodendrocyte lineage cells from mouse cortices by immunopanning","volume":"2013","author":"Emery","year":"2013","journal-title":"Cold Spring Harbor Prot."},{"key":"10.1016\/j.ymgme.2024.108497_bb0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2010.04.026","article-title":"Semi-automated Sholl analysis for quantifying changes in growth and differentiation of neurons and glia","volume":"190","author":"Gensel","year":"2010","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.ymgme.2024.108497_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymgme.2024.108497_bb0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/hmg\/10.11.1191","article-title":"A mutation in the saposin a domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse","volume":"10","author":"Matsuda","year":"2001","journal-title":"Human Mol. Gent."},{"key":"10.1016\/j.ymgme.2024.108497_bb0165","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00005072-199906000-00009","article-title":"An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy","volume":"58","author":"Taniike","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2024.108497_bb0170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1097-4547(20000115)59:2<170::AID-JNR3>3.0.CO;2-G","article-title":"Biochemistry and neuropathology of mice doubly deficient in synthesis and degradation of galactosylceramide","volume":"59","author":"Ezoe","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2024.108497_bb0175","doi-asserted-by":"crossref","first-page":"1279985","DOI":"10.3389\/fnmol.2023.1279985","article-title":"Insights on therapeutic potential of clemastine in neurological disorders","volume":"16","author":"Jiang","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymgme.2024.108497_bb0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fmed.2020.00331","article-title":"Selective thyroid hormone receptor-beta (TR\u03b2) agonists: new perspectives for the treatment of metabolic and neurodegenerative disorders","volume":"7","author":"Saponaro","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ymgme.2024.108497_bb0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-4547(20000415)60:2<231::AID-JNR12>3.0.CO;2-E","article-title":"L-cycloserine slows the clinical and pathological course in mice with globoid cell leukodystrophy (twitcher mice)","volume":"60","author":"LeVine","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2024.108497_bb0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1447-0756.1989.tb00171.x","article-title":"Leukoencephalopathy following treatment with carmofur: a case report and review of the Japanese literature","volume":"15","author":"Yamada","year":"1989","journal-title":"Asia-Oceania J. Obst. Gynaecol."},{"key":"10.1016\/j.ymgme.2024.108497_bb0195","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1038\/s41598-021-93601-1","article-title":"Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor","volume":"11","author":"Babcock","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224003810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:39:37Z","timestamp":1720611577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224003810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1096719224003810"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108497","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promyelinating drugs ameliorate oligodendrocyte pathologies in a mouse model of Krabbe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108497"}}